Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inamed promises higher EPS (earnings per share) despite lower sales:

This article was originally published in Clinica

Executive Summary

Inamed, a manufacturer of products for the plastic and reconstructive surgery, and obesity markets, says its sales will be lower than its mid-quarter sales update. However, second-quarter earnings per share will be at the higher end of analyst expectations, the Santa Barbara, California company says. Inamed has achieved higher earnings because it had been able to control costs. Sales were down because of the strong dollar, weaker economies in Japan and Europe, and continued weakness in the US economy.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT072041

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel